Skip to main content
. 2021 Sep 21;12(1):7177–7193. doi: 10.1080/21655979.2021.1979442

Figure 5.

Figure 5.

APCDD1L-AS1 serves as a sponge for miR-1224-5p in 5-FU-resistant OSCC cells

(A) The binding sites between miR-1224-5p and APCDD1L-AS1 were shown by Starbase software. (B) RT-qPCR was performed to measure miR-1224-5p level in HSC-3/5-FU and HN-4/5-FU cells transfected with NC mimics and miR-1224-5p mimics. (C and D) Dual-luciferase reporter assay was performed to validate the combination between miR-1224-5p and APCDD1L-AS1 in 5-FU-resistant OSCC cells. (E and F) RIP assay was performed to confirm the target relationship between miR-1224-5p and APCDD1L-AS1 in 5-FU-resistant OSCC cells. (G) miR-1224-5p expression in OSCC tissues and normal tissues was determined by RT-qPCR. (H) miR-1224-5p expression was examined in 5-FU-sensitive and 5-FU-resistant OSCC tissues. (I) RT-qPCR was performed to measure APCDD1L-AS1 level in HSC-3/5-FU and HN-4/5-FU cells transfected with Vector and oe-APCDD1L-AS1. (J and K) RT-qPCR was performed to detect miR-1224-5p expression in HSC-3/5-FU and HN-4/5-FU cells transfected with sh-NC, sh-APCDD1L-AS1, Vector or oe-APCDD1L-AS1. (L) MiR-1224-5p expression was detected in HSC-3/5-FU and HN-4/5-FU cells transfected with NC inhibitor or miR-1224-5p inhibitor. (M and N) RT-qPCR was performed to detect APCDD1L-AS1 expression HSC-3/5-FU and HN-4/5-FU cells transfected with NC inhibitor, miR-1224-5p inhibitor, NC mimics, or miR-1224-5p mimics. **P < 0.01, ***P < 0.001.